These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37170791)

  • 41. [CIDP Refractory to Three Types of Mainstay Treatments: Differential Diagnosis and Treatment Strategies].
    Iijima M
    Brain Nerve; 2022 May; 74(5):517-524. PubMed ID: 35589641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
    Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study.
    Echaniz-Laguna A; de Séze J; Chanson JB
    J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):699-705. PubMed ID: 22577230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic inflammatory demyelinating polyneuropathy.
    Mathey EK; Pollard JD
    J Neurol Sci; 2013 Oct; 333(1-2):37-42. PubMed ID: 23146613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC).
    Bus SRM; Zambreanu L; Abbas A; Rajabally YA; Hadden RDM; de Haan RJ; de Borgie CAJM; Lunn MP; van Schaik IN; Eftimov F;
    Trials; 2021 Feb; 22(1):155. PubMed ID: 33608058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of chronic inflammatory demyelinating polyneuropathy.
    van Doorn PA; Ruts L
    Curr Opin Neurol; 2004 Oct; 17(5):607-13. PubMed ID: 15367865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy.
    Silwal A; Pitt M; Phadke R; Mankad K; Davison JE; Rossor A; DeVile C; Reilly MM; Manzur AY; Muntoni F; Munot P
    Neuromuscul Disord; 2018 Sep; 28(9):757-765. PubMed ID: 30072201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Puyade M; Labeyrie C; Badoglio M; Cintas P; Guenounou S; Lansiaux P; Marjanovic Z; Nicolas G; Pomies A; Terriou L; Torregrosa Diaz JM; Baron C; Castilla Llorente C; Yakoub-Agha I; Farge D
    Bull Cancer; 2020 Jan; 107(1S):S104-S113. PubMed ID: 31818426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
    Hughes RA
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.
    Racosta JM; Sposato LA; Kimpinski K
    Muscle Nerve; 2017 Jun; 55(6):802-809. PubMed ID: 27649063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.
    Malik A; Berry R; Fung BM; Tabibian JH
    Clin J Gastroenterol; 2021 Feb; 14(1):1-13. PubMed ID: 33146871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.
    Rodríguez Y; Vatti N; Ramírez-Santana C; Chang C; Mancera-Páez O; Gershwin ME; Anaya JM
    J Autoimmun; 2019 Aug; 102():8-37. PubMed ID: 31072742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
    Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
    Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
    Tracy JA; Dyck PJ
    Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.
    Kuitwaard K; van Doorn PA; Bengrine T; van Rijs W; Baas F; Nagelkerke SQ; Kuijpers TW; Fokkink WR; Bunschoten C; Broers MC; Willemsen SP; Jacobs BC; Huizinga R
    Eur J Neurol; 2021 May; 28(5):1677-1683. PubMed ID: 33460483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.
    Saperstein DS; Barohn RJ
    Curr Neurol Neurosci Rep; 2003 Jan; 3(1):57-63. PubMed ID: 12507413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
    Van den Bergh PYK; van Doorn PA; Hadden RDM; Avau B; Vankrunkelsven P; Allen JA; Attarian S; Blomkwist-Markens PH; Cornblath DR; Eftimov F; Goedee HS; Harbo T; Kuwabara S; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Sommer C; Topaloglu HA
    J Peripher Nerv Syst; 2021 Sep; 26(3):242-268. PubMed ID: 34085743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
    van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
    Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Bunschoten C; Jacobs BC; Van den Bergh PYK; Cornblath DR; van Doorn PA
    Lancet Neurol; 2019 Aug; 18(8):784-794. PubMed ID: 31076244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus.
    Julio PR; Cortês MMM; Costallat LTL; Gaino JZ; França MC; Appenzeller S
    Semin Arthritis Rheum; 2021 Feb; 51(1):158-165. PubMed ID: 33383292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.